Alliance Pharma Plc (APH) - Financial and Strategic SWOT Analysis Review by GlobalData

VIEWS: 56 PAGES: 33

More Info
									            Alliance Pharma Plc (APH) - Financial and Strategic SWOT Analysis
                                          Review
        Reference Code: GDPH123619FSA                                                                                            Publication Date: JUL 2013

          Avonbridge House, Bath Road                       Phone               +44 1249 466966                     Revenue         44.90 (million GBP)
          Chippenham, Wiltshire                             Fax                 +44 1249 466977                     Net Profit      8.69 (million GBP)
          SN15 2BB                                          Website             www.alliancepharma.co.uk            Employees       63
                                                                                APH      [SEATS         (AIM                        Pharmaceuticals            &
          United Kingdom                                    Exchange                                                Industry
                                                                                Market)]                                            Healthcare

       Company Overview
       Alliance Pharma plc (Alliance) is a specialty pharmaceutical company. The company focuses acquisition, licensing, registration
       and marketing of pharmaceutical products. It promotes more than fifty acquired and licensed prescription products across various
       therapeutic categories. The company has specialization in two areas, namely, Dermatology and Secondary Care. The company’s
       Dermatology product portfolio comprises comprise Acnisal, Dermamist, Occlusal, Hydromol, Pentrax, Atarax, Naseptin, Timodine,
       Alphaderm, Isotretinoin, Permitabs,Aquadrate, Meted and Quinoderm.
       Key Executives                                                                SWOT Analysis
                      Name                                 Title                      Alliance Pharma Plc, SWOT Analysis
         John Dawson                         Chief Executive Officer                  Strengths                             Weaknesses
         Richard Wright                      Director, Finance
                                                                                      Strong Brand Image                    Dependence on the UK Market
         Tony Booley                         Director
                                                                                      Improved Profit Margins               Limited Customer Base
         Peter Butterfield                   Director
         Michael R B Gatenby                 Chairman
        Source: Annual Report, Company Website, Primary and Secondary
                                                                                      Opportunities                         Threats
        Research, GlobalData
                                                                                      Strategic Acquisitions                Growing Parallel Trade
       Share Data
                                                                                      Emerging Markets                      Cost Containment Pressures
         Alliance Pharma Plc
        Share Price (GBP) as on 26-Jul-                                  0.32
        2013                                                                         Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData
        EPS (GBP)                                                        0.03
        Market Cap (million GBP)                                           80
        Enterprise Value (million GBP)                                   103
        Shares Outstanding (million)                                     250
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData

       Financial Performance                                                         Recent Developments
                                                                                      Mar 21, 2013         Alliance Pharma Reports 2012 Results
                                                                                      Sep 12, 2012         Alliance Pharma Reports Revenue Of £22m In
                                                                                                           H1 2012
                                                                                      Mar 22, 2012         Alliance Pharma Reports Revenue Of £46m In
                                                                                                           2011
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData




       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData




Alliance Pharma Plc (APH) - Financial and Strategic SWOT                                                                         Reference Code: GDPH123619FSA
Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                         Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Section 1 - About the Company.......................................................................................................................................................... 4
       Alliance Pharma Plc - Key Facts ........................................................................................................................................................ 4
       Alliance Pharma Plc - Key Employees ............................................................................................................................................... 5
       Alliance Pharma Plc - Key Employee Biographies ............................................................................................................................. 6
       Alliance Pharma Plc - Major Products and Services .......................................................................................................................... 7
       Alliance Pharma Plc - History ............................................................................................................................................................. 9
       Alliance Pharma Plc - Company Statement...................................................................................................................................... 11
       Alliance Pharma Plc - Locations And Subsidiaries ........................................................................................................................... 13
          Head Office ................................................................................................................................................................................... 13
          Other Locations & Subsidiaries ..................................................................................................................................................... 13
       Section 2 – Company Analysis ......................................................................................................................................................... 14
       Alliance Pharma Plc - Business Description ..................................................................................................................................... 14
       Alliance Pharma Plc - SWOT Analysis ............................................................................................................................................. 15
          SWOT Analysis - Overview........................................................................................................................................................... 15
          Alliance Pharma Plc - Strengths ................................................................................................................................................... 15
             Strength - Strong Brand Image ................................................................................................................................................. 15
             Strength - Improved Profit Margins ........................................................................................................................................... 15
             Strength - Partnership Agreements ........................................................................................................................................... 15
          Alliance Pharma Plc - Weaknesses .............................................................................................................................................. 15
             Weakness - Dependence on the UK Market ............................................................................................................................. 15
             Weakness - Limited Customer Base ......................................................................................................................................... 16
          Alliance Pharma Plc - Opportunities ............................................................................................................................................. 16
             Opportunity - Strategic Acquisitions .......................................................................................................................................... 16
             Opportunity - Emerging Markets ............................................................................................................................................... 16
             Opportunity - Changing Demographics ..................................................................................................................................... 16
          Alliance Pharma Plc - Threats ...................................................................................................................................................... 17
             Threat - Growing Parallel Trade ................................................................................................................................................ 17
             Threat - Cost Containment Pressures ....................................................................................................................................... 17
             Threat - Product Liability Claims ............................................................................................................................................... 17
       Alliance Pharma Plc - Key Competitors ............................................................................................................................................ 18
       Section 3 – Company Financial Ratios ............................................................................................................................................. 19
       Financial Ratios - Capital Market Ratios............................................................................................................................
								
To top